• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单细胞转录组分析揭示了 ccRCC 中的肿瘤内异质性,这导致了不同的临床结果。

Single-Cell Transcriptome Analysis Reveals Intratumoral Heterogeneity in ccRCC, which Results in Different Clinical Outcomes.

机构信息

Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Shenzhen Huazhong University of Science and Technology Research Institute, Shenzhen, China.

Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

出版信息

Mol Ther. 2020 Jul 8;28(7):1658-1672. doi: 10.1016/j.ymthe.2020.04.023. Epub 2020 Apr 29.

DOI:10.1016/j.ymthe.2020.04.023
PMID:32396851
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7335756/
Abstract

Clear-cell renal cell carcinoma (ccRCC) is the most common histological type of RCC. To investigate the intratumoral heterogeneity of ccRCC, we analyzed single-cell RNA-sequencing data and identified 15 major cell types, along with 39 subgroups of cells derived from tumor or non-malignant tissues, and confirmed their presence by immunofluorescence staining in tissue chips. In this study, we verified that T cell exhaustion was the key factor responsible for the immunosuppressive property of ccRCC tissues, which was significantly related to poor prognosis. We also found that abnormal metabolic patterns occurred not only in cancer cells, but also in tumor-infiltrating stromal cells. Based on the fraction of each cell cluster detected by CIBERSORTx, 533 patients from The Cancer Genome Atlas (TCGA) KIRC dataset were divided into three groups. One group, which showed a lesser proportion of activated CD8 cells and greater proportion of exhausted CD8 cells, was associated with a poor prognosis. Hence, the blockade of immunosuppressive checkpoints, not only PD-1, but also LAG3, TIM-3, and other inhibitory checkpoints, could serve as a potential target for ccRCC immunotherapy. Our work will further the understanding of the heterogeneity among ccRCC tissues and provide novel strategies for treating ccRCC.

摘要

透明细胞肾细胞癌(ccRCC)是 RCC 中最常见的组织学类型。为了研究 ccRCC 的肿瘤内异质性,我们分析了单细胞 RNA 测序数据,鉴定出 15 种主要细胞类型,以及 39 个源自肿瘤或非恶性组织的细胞亚群,并通过组织芯片中的免疫荧光染色证实了它们的存在。在这项研究中,我们验证了 T 细胞耗竭是 ccRCC 组织免疫抑制特性的关键因素,这与预后不良显著相关。我们还发现异常代谢模式不仅发生在癌细胞中,也发生在肿瘤浸润的基质细胞中。基于 CIBERSORTx 检测到的每个细胞簇的比例,从癌症基因组图谱(TCGA)KIRC 数据集的 533 名患者被分为三组。一组表现出较少比例的激活 CD8 细胞和较多比例的耗竭 CD8 细胞,与预后不良相关。因此,抑制免疫检查点,不仅是 PD-1,还有 LAG3、TIM-3 和其他抑制性检查点,可能成为 ccRCC 免疫治疗的潜在靶点。我们的工作将进一步加深对 ccRCC 组织异质性的理解,并为治疗 ccRCC 提供新的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/7335756/8ae9214d36eb/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/7335756/8ae9214d36eb/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/7335756/8ae9214d36eb/fx1.jpg

相似文献

1
Single-Cell Transcriptome Analysis Reveals Intratumoral Heterogeneity in ccRCC, which Results in Different Clinical Outcomes.单细胞转录组分析揭示了 ccRCC 中的肿瘤内异质性,这导致了不同的临床结果。
Mol Ther. 2020 Jul 8;28(7):1658-1672. doi: 10.1016/j.ymthe.2020.04.023. Epub 2020 Apr 29.
2
The integrate profiling of single-cell and spatial transcriptome RNA-seq reveals tumor heterogeneity, therapeutic targets, and prognostic subtypes in ccRCC.单细胞和空间转录组 RNA-seq 的综合分析揭示了 ccRCC 中的肿瘤异质性、治疗靶点和预后亚型。
Cancer Gene Ther. 2024 Jun;31(6):917-932. doi: 10.1038/s41417-024-00755-x. Epub 2024 Mar 13.
3
Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.综合多组学鉴定干扰素-γ反应特征表明 RBCK1 调节肾细胞癌的免疫抑制微环境。
Front Immunol. 2021 Nov 2;12:734646. doi: 10.3389/fimmu.2021.734646. eCollection 2021.
4
A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.基于免疫基因组学的透明细胞肾细胞癌新型预后模型。
Int Immunopharmacol. 2021 Jan;90:107119. doi: 10.1016/j.intimp.2020.107119. Epub 2020 Nov 24.
5
Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.构建具有预后意义的新型免疫相关 lncRNA 对用于肾透明细胞肾细胞癌。
Dis Markers. 2021 Sep 1;2021:8800358. doi: 10.1155/2021/8800358. eCollection 2021.
6
Unravelling infiltrating T-cell heterogeneity in kidney renal clear cell carcinoma: Integrative single-cell and spatial transcriptomic profiling.解析肾透明细胞癌浸润性 T 细胞异质性:整合单细胞和空间转录组分析。
J Cell Mol Med. 2024 Jun;28(12):e18403. doi: 10.1111/jcmm.18403.
7
Dissecting LncRNA Roles in Renal Cell Carcinoma Metastasis and Characterizing Genomic Heterogeneity by Single-Cell RNA-seq.通过单细胞 RNA-seq 解析长链非编码 RNA 在肾细胞癌转移中的作用并表征基因组异质性。
Mol Cancer Res. 2018 Dec;16(12):1879-1888. doi: 10.1158/1541-7786.MCR-17-0776. Epub 2018 Aug 6.
8
Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.胎盘特异性8的过表达与透明细胞肾细胞癌的恶性进展及不良预后相关。
Int Urol Nephrol. 2017 Jul;49(7):1165-1176. doi: 10.1007/s11255-017-1578-y. Epub 2017 Mar 27.
9
A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.一种新型的 10 个糖酵解相关基因特征可预测透明细胞肾细胞癌的总生存期。
BMC Cancer. 2021 Apr 9;21(1):381. doi: 10.1186/s12885-021-08111-0.
10
Anoikis resistance regulates immune infiltration and drug sensitivity in clear-cell renal cell carcinoma: insights from multi omics, single cell analysis and experiment.失巢凋亡抵抗调节透明细胞肾细胞癌中的免疫浸润和药物敏感性:多组学、单细胞分析和实验的见解。
Front Immunol. 2024 Jun 17;15:1427475. doi: 10.3389/fimmu.2024.1427475. eCollection 2024.

引用本文的文献

1
[A risk prediction model for prognosis and immunotherapy response in prostate cancer patients based on immunosuppressive neutrophil Neu_2 subsets].基于免疫抑制性中性粒细胞Neu_2亚群的前列腺癌患者预后及免疫治疗反应风险预测模型
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Aug 20;45(8):1643-1653. doi: 10.12122/j.issn.1673-4254.2025.08.09.
2
Immune microenvironment and prognostic genes of triple-negative breast cancer in the context of transcriptome and single-cell sequencing.转录组和单细胞测序背景下三阴性乳腺癌的免疫微环境与预后基因
Sci Rep. 2025 Aug 13;15(1):29614. doi: 10.1038/s41598-025-15157-8.
3
WD40 Protein NLE1 as a Novel Diagnostic Biomarker Promoting Hepatocellular Carcinoma Proliferation.

本文引用的文献

1
A single-nucleus RNA-sequencing pipeline to decipher the molecular anatomy and pathophysiology of human kidneys.一种用于解析人类肾脏分子解剖结构和病理生理学的单细胞核 RNA 测序工作流程。
Nat Commun. 2019 Jun 27;10(1):2832. doi: 10.1038/s41467-019-10861-2.
2
Safe Use of Immune Checkpoint Inhibitors in the Multidisciplinary Management of Urological Cancer: The European Association of Urology Position in 2019.免疫检查点抑制剂在泌尿系统癌症多学科管理中的安全使用:欧洲泌尿外科学会 2019 年立场。
Eur Urol. 2019 Sep;76(3):368-380. doi: 10.1016/j.eururo.2019.05.041. Epub 2019 Jun 21.
3
TOX is a critical regulator of tumour-specific T cell differentiation.
WD40蛋白NLE1作为一种促进肝细胞癌增殖的新型诊断生物标志物。
Clin Med Insights Oncol. 2025 Jul 1;19:11795549251348902. doi: 10.1177/11795549251348902. eCollection 2025.
4
RDM1 plays an oncogenic role in clear cell renal cell carcinoma potentially by modulating MCM2.RDM1可能通过调节MCM2在透明细胞肾细胞癌中发挥致癌作用。
Sci Rep. 2025 Jul 2;15(1):22649. doi: 10.1038/s41598-025-07230-z.
5
Near-infrared light-induced photothermal and immunotherapy system for lung cancer bone metastasis treatment with simultaneous bone repair.用于肺癌骨转移治疗并同步进行骨修复的近红外光诱导光热和免疫治疗系统。
Bioact Mater. 2025 Jun 10;52:182-199. doi: 10.1016/j.bioactmat.2025.06.008. eCollection 2025 Oct.
6
A novel glycogene-related signature for prognostic prediction and immune microenvironment assessment in kidney renal clear cell carcinoma.一种用于肾透明细胞癌预后预测和免疫微环境评估的新型糖原相关特征。
Ann Med. 2025 Dec;57(1):2495762. doi: 10.1080/07853890.2025.2495762. Epub 2025 May 7.
7
TRIM36 serves as a prognostic indicator linked to immune infiltration in KIRC.TRIM36作为与肾透明细胞癌中免疫浸润相关的预后指标。
Heliyon. 2025 Feb 7;11(4):e42540. doi: 10.1016/j.heliyon.2025.e42540. eCollection 2025 Feb 28.
8
Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma.可溶性TIM-3可能由髓样细胞产生,可预测转移性透明细胞肾细胞癌对免疫检查点抑制剂的耐药性。
J Exp Clin Cancer Res. 2025 Feb 14;44(1):54. doi: 10.1186/s13046-025-03293-y.
9
Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system.利用纳米技术克服中枢神经系统疾病中的血脑屏障。
Mater Today Bio. 2025 Jan 4;31:101457. doi: 10.1016/j.mtbio.2025.101457. eCollection 2025 Apr.
10
Identification and validation of prognostic biomarkers in ccRCC: immune-stromal score and survival prediction.肾透明细胞癌中预后生物标志物的鉴定与验证:免疫-基质评分与生存预测
BMC Cancer. 2025 Jan 27;25(1):148. doi: 10.1186/s12885-025-13534-0.
TOX 是肿瘤特异性 T 细胞分化的关键调节因子。
Nature. 2019 Jul;571(7764):270-274. doi: 10.1038/s41586-019-1324-y. Epub 2019 Jun 17.
4
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts.跨物种胰腺导管腺癌单细胞分析揭示了抗原呈递的癌相关成纤维细胞。
Cancer Discov. 2019 Aug;9(8):1102-1123. doi: 10.1158/2159-8290.CD-19-0094. Epub 2019 Jun 13.
5
Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth.肿瘤细胞劫持巨噬细胞产生的补体 C1q 以促进肿瘤生长。
Cancer Immunol Res. 2019 Jul;7(7):1091-1105. doi: 10.1158/2326-6066.CIR-18-0891. Epub 2019 Jun 4.
6
Mucosal expression of S100A12 (calgranulin C) and S100A8/A9 (calprotectin) and correlation with serum and fecal concentrations in dogs with chronic inflammatory enteropathy.慢性炎症性肠病犬中S100A12(钙粒蛋白C)和S100A8/A9(钙卫蛋白)的黏膜表达及其与血清和粪便浓度的相关性
Vet Immunol Immunopathol. 2019 May;211:64-74. doi: 10.1016/j.vetimm.2019.04.003. Epub 2019 May 6.
7
Towards individualized therapy for metastatic renal cell carcinoma.迈向转移性肾细胞癌的个体化治疗。
Nat Rev Clin Oncol. 2019 Oct;16(10):621-633. doi: 10.1038/s41571-019-0209-1.
8
Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets.人类肿瘤相关巨噬细胞和单核细胞转录图谱揭示了癌症特异性重编程、生物标志物和治疗靶点。
Cancer Cell. 2019 Apr 15;35(4):588-602.e10. doi: 10.1016/j.ccell.2019.02.009. Epub 2019 Mar 28.
9
The adjuvant treatment of kidney cancer: a multidisciplinary outlook.肾癌的辅助治疗:多学科视角。
Nat Rev Nephrol. 2019 Jul;15(7):423-433. doi: 10.1038/s41581-019-0131-x.
10
A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma.KLF6 驱动的转录网络将脂代谢平衡与肾癌肿瘤生长联系起来。
Nat Commun. 2019 Mar 11;10(1):1152. doi: 10.1038/s41467-019-09116-x.